Sichuan Cancer Hospital and Research Institute
Chengdu, Sichuan, 610000, China
NCT Number: NCT06325592
This study aimed to analyze perioperative information in patients with high-grade squamous intraepithelial lesion (HSIL) undergoing total hysterectomy (TH), offering insights into optimal surgery timing, selecting the operation path, and enhancing surgical operation details.
Looking for future studies?
Notify MeFemale
Observational
Chengdu, Sichuan, 610000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
surgical timing; laparoscopic hysterectomy or abdominal hysterectomy
Time frame: Within 7 days of surgery
Use a thermometer to measure your temperature
Time frame: Within 7 days of surgery
Postoperative therapeutic use of antibiotics
Time frame: Within 7 days of surgery
Postoperative complications
Time frame: Date of surgery to date of discharge
Postoperative hospitalization days
Time frame: Within 7 days of surgery
Postoperative hemoglobin
Time frame: Within 7 days of surgery
Postoperative white blood cell count
Time frame: Within 7 days of surgery
Postoperative erythrocyte count
Time frame: Within 7 days of surgery
Postoperative albumin number
Time frame: Within 7 days of surgery
Postoperative CRP value
Sichuan Cancer Hospital and Research Institute
Other
Association Between Surgical Timing and Route of Total Hysterectomy After Loop Electrosurgical Excision Procedure and Perioperative Risk in Patients With Cervical High-grade Squamous Intraepithelial Lesion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06651957
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
San Francisco, California, United States
View Trial DetailsNCT03920800
High-Grade Squamous Intraepithelial Lesions, Morphological and Microscopic Findings
Brussels, Belgium
View Trial DetailsNCT04177641
High-Grade Squamous Intraepithelial Lesions, Low Grade Squamous Intraepithelial Lesion
Muğla, Turkey (Türkiye)
View Trial DetailsNCT03239223
CIN, Cervical Cancer
Los Angeles, California, United States
View Trial Details